ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 138 filers reported holding ARCELLX INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $141,605,084 | +13.5% | 3,946,630 | 0.0% | 72.57% | +34.9% |
| Q2 2023 | $124,792,441 | -26.4% | 3,946,630 | -28.2% | 53.81% | -14.7% |
| Q1 2023 | $169,455,216 | -0.5% | 5,500,007 | 0.0% | 63.12% | +1.5% |
| Q4 2022 | $170,390,217 | +65.1% | 5,500,007 | 0.0% | 62.20% | +31.8% |
| Q3 2022 | $103,235,000 | +3.8% | 5,500,007 | 0.0% | 47.19% | -3.0% |
| Q2 2022 | $99,440,000 | +29.0% | 5,500,007 | 0.0% | 48.67% | +23.3% |
| Q1 2022 | $77,110,000 | – | 5,500,007 | – | 39.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $169,455,216 | 63.12% |
| NEA Management Company, LLC | 4,745,262 | $146,201,522 | 10.11% |
| Samsara BioCapital, LLC | 909,579 | $28,024,129 | 5.79% |
| Paradigm Biocapital Advisors LP | 1,757,779 | $54,157,171 | 5.13% |
| Soleus Capital Management, L.P. | 1,248,147 | $38,455,409 | 3.98% |
| Perceptive Advisors | 3,841,739 | $118,363,979 | 3.50% |
| Cormorant Asset Management, LP | 1,600,000 | $49,296 | 3.25% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,398,321 | $73,892,270 | 3.12% |
| Altium Capital Management LP | 150,000 | $4,621,500 | 2.56% |
| Novo Holdings A/S | 1,225,000 | $37,742,250 | 2.49% |